DAY ONE Trademark

Trademark Overview

On Wednesday, November 14, 2018, a trademark application was filed for DAY ONE with the United States Patent and Trademark Office. The USPTO has given the DAY ONE trademark a serial number of 88193233. The federal status of this trademark filing is REGISTERED as of Tuesday, April 11, 2023. This trademark is owned by Hero Therapeutics, Inc.. The DAY ONE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer, autoimmune disorders, and neurological disorders
day one

General Information

Serial Number88193233
Word MarkDAY ONE
Filing DateWednesday, November 14, 2018
Status700 - REGISTERED
Status DateTuesday, April 11, 2023
Registration Number7026051
Registration DateTuesday, April 11, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer, autoimmune disorders, and neurological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 1, 2018
Primary Code005
First Use Anywhere DateThursday, September 30, 2021
First Use In Commerce DateThursday, September 30, 2021

Trademark Owner History

Party NameDAY ONE BIOPHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
Party NameDAY ONE BIOPHARMACEUTICALS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
Party NameHero Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
Party NameHero Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Friday, September 22, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 22, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 22, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 22, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 22, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 11, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 11, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, March 8, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 7, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, February 20, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 16, 2023USE AMENDMENT FILED
Thursday, February 16, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, October 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 17, 2022SOU EXTENSION 5 GRANTED
Wednesday, October 12, 2022SOU EXTENSION 5 FILED
Wednesday, October 12, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, April 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 25, 2022SOU EXTENSION 4 GRANTED
Friday, April 22, 2022SOU EXTENSION 4 FILED
Friday, April 22, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 15, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 7, 2021SOU EXTENSION 3 GRANTED
Tuesday, October 5, 2021SOU EXTENSION 3 FILED
Tuesday, October 5, 2021SOU TEAS EXTENSION RECEIVED
Friday, April 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 14, 2021SOU EXTENSION 2 GRANTED
Wednesday, April 14, 2021SOU EXTENSION 2 FILED
Wednesday, April 14, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, February 3, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, October 31, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 30, 2020SOU EXTENSION 1 GRANTED
Wednesday, October 21, 2020SOU EXTENSION 1 FILED
Friday, October 30, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 21, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, April 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 18, 2020TTAB RELEASE CASE TO TRADEMARKS
Wednesday, March 18, 2020OPPOSITION TERMINATED NO. 999999
Wednesday, March 18, 2020OPPOSITION DISMISSED NO. 999999
Friday, August 9, 2019OPPOSITION INSTITUTED NO. 999999
Wednesday, May 22, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 11, 2019ASSIGNED TO LIE
Tuesday, February 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 19, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, February 19, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 19, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, February 19, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 19, 2019ASSIGNED TO EXAMINER
Saturday, December 1, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 17, 2018NEW APPLICATION ENTERED

Related Keywords

disorders neurological autoimmune cancer preparations treatment pharmaceutical